HSD17B13 [TA] (hydroxysteroid 17-beta dehydrogenase 13) encodes a hepatic lipid droplet protein and is associated with a protective effect against cirrhosis in fatty liver diseases due to NAFLD or alcohol [53]. This evidence concerns the gene HSD17B13 and metabolic dysfunction-associated steatotic liver disease.